| 摘要 |
<p>Pharmaceutical compositions for treatment of eye disorders employ ocular hypotensive compounds of the formula (I); <CHEM> (wherein: R<1> is selected from hydrogen, C1-C6 alkyl, and C1-C6 alkoxy; each R<2> is selected from hydrogen, C1-C6 alkyl, halogen, nitro or carboxy; R<3> is selected from heterocyclic, amino, mono-substituted amino, and di-substituted amino, A and B each represents C1-C6 alkylene, X represents -NH- or -CH2-; and n is 1, 2 or 3) or pharmaceutically acceptable salts or esters thereof.</p> |
